UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback